Across Europe, healthcare policy makers share the same challenges:
There is, therefore, an urgent need to achieve safe, sustainable, efficient approaches to the appropriate use of prescription medications.
The SIMPATHY (Stimulating Innovation Management of Polypharmacy and Adherence in The Elderly) project, co-funded by the third EU Health Programme, brings together ten partners from across Europe to address challenges in health service provision and sustainable management of medication among the elderly. The project aims to deliver the necessary change in management approaches and tools to help manage multi-medication and adherence to prescribed drugs.
We would like to invite you to attend our final conference, where we will share the good practice identified; the components required to optimise impact and demonstrate new tools to gather evidence on the potential economic impact of improved approaches to polypharmacy. It is our hope that this conference will inspire you – as health leaders, professionals and key stakeholders – to adopt new approaches to improve outcomes for EU citizens from medicines and achieve efficiencies.
The interactive event will explore opportunities for further European initiatives to improve the management of polypharmacy and support change across the EU. Participants will also hear from the European Commission’s DG Health and the WHO putting this challenge in a European and global context. In addition, a pre-eminent thought leader from Harvard University will give a keynote address on the importance of leadership in healthcare change management.
We look forward to meet you in Scotland House, Brussels on 27 April 2017
Organiser of Active and healthy ageing – Addressing the challenges of multi-medication in Europe’s elderly population
The SIMPATHY project has been co-funded by the third EU Health Programme. The project consortium brings together ten partners from eight EU Member States.
SIMPATHY aims to stimulate, promote and support innovation across the EU in the management of appropriate polypharmacy and adherence in the elderly. We contribute to efficient and sustainable healthcare systems and impact health outcomes and quality of life of patients with multimorbidity.
Specifically, we aim to raise awareness and engender high-level commitment to the need to change how prescribing and multi-drug use is managed in order to realise the patent and healthcare systems benefits.
The project has demonstrated that the impact of improving prescribing is optimised through the use of multi-disciplinary teams, including pharmacists, to improve the quality of prescribing; where there is inspirational leadership to promote change and where efficiencies can be demonstrated with robust evidence.
The key messages of SIMPATHY:
This document is part of SIMPATHY project (663082), which has received funding from the European Union’s Health Programme (2014-2020).